# A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™

> **NCT04179786** · PHASE4 · COMPLETED · sponsor: **VBI Vaccines Inc.** · enrollment: 91 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** Sci-B-Vac™

## Key facts

- **NCT ID:** NCT04179786
- **Lead sponsor:** VBI Vaccines Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-01
- **Primary completion:** 2017-02-07
- **Final completion:** 2017-04-25
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2022-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04179786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04179786, "A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04179786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*